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Key points 1 
 2 
• The in vivo fetal cardiovascular defence to chronic hypoxia has remained by and large an 3 
enigma because no technology has been available to induce significant and prolonged fetal 4 
hypoxia whilst recording longitudinal changes in fetal regional blood flow as the hypoxic 5 
pregnancy is developing; 6 
 7 
• We introduce a new technique able to maintain chronically instrumented maternal and fetal 8 
sheep preparations under isobaric chronic hypoxia for most of gestation, beyond levels that 9 
can be achieved by high altitude and of relevance in magnitude to the human IUGR fetus; 10 
 11 
• This technology permits wireless recording in free-moving animals of longitudinal maternal 12 
and fetal cardiovascular function, including beat-to-beat alterations in pressure and blood flow 13 
signals in regional circulations; 14 
 15 
• The relevance and utility of the technique is presented by testing the hypotheses that the fetal 16 
circulatory brain sparing response persists during chronic fetal hypoxia and that an increase in 17 
ROS in the fetal circulation is an involved mechanism. 18 
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Abstract 19 
 20 
Although the fetal cardiovascular defence to acute hypoxia and the physiology underlying it have been 21 
established for decades, how the fetal cardiovascular system responds to chronic hypoxia has been 22 
comparatively understudied.  We designed and created isobaric hypoxic chambers able to maintain 23 
pregnant sheep for prolonged periods of gestation under controlled significant (10% O2) hypoxia, 24 
yielding fetal mean PaO2 levels (11.5±0.6 mmHg) similar to those measured in human fetuses of 25 
hypoxic pregnancy.  We also created a wireless data acquisition system able to record fetal blood flow 26 
signals in addition to fetal blood pressure and heart rate from free moving ewes as the hypoxic 27 
pregnancy is developing.  We determined in vivo longitudinal changes in fetal cardiovascular function 28 
including parallel measurement of fetal carotid and femoral blood flow and oxygen and glucose 29 
delivery during the last third of gestation.  The ratio of oxygen (from 2.7±0.2 to 3.8±0.8; P<0.05) and 30 
of glucose (from 2.3±0.1 to 3.3±0.6; P<0.05) delivery to the fetal carotid, relative to the fetal femoral 31 
circulation increased during and shortly after the period of chronic hypoxia. In contrast, oxygen and 32 
glucose delivery remained unchanged from baseline in normoxic fetuses.  Fetal plasma urate 33 
concentration increased significantly during chronic hypoxia but not during normoxia (∆: 4.8±1.6 vs. 34 
0.5±1.4 µmol.L-1, P<0.0.05).  The data support the hypotheses tested and show persisting 35 
redistribution of substrate delivery away from peripheral and towards essential circulations in the 36 
chronically hypoxic fetus, associated with increases in xanthine oxidase-derived ROS.   37 
 38 
Abbreviations:  ROS, reactive oxygen species; XO, xanthine oxidase; IUGR, intrauterine growth 39 
restriction; •O2-, superoxide anion; NO, nitric oxide. 40 
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Introduction 41 
 42 
The phrase ‘Everest in utero’ was coined by Sir Joseph Barcroft to highlight that the fetus develops 43 
under conditions of relative hypoxia compared with the oxygenation of the adult individual (Barcroft 44 
et al. 1933). Low oxygen tension in fetal life is essential for normal placental development as well as 45 
appropriate formation and maturation of the fetal cardiovascular system (Compernolle et al. 2003; 46 
Burton, 2009).  However, reductions in fetal oxygenation below baseline can be harmful to the 47 
developing fetus unless appropriate compensatory responses are triggered.  Short term, acute episodes 48 
of fetal hypoxia are common in late gestation, such as those occurring during transient compression of 49 
the umbilical cord (Giussani et al. 1997) or those resulting from myometrial contractions during 50 
labour and delivery (Huch et al. 1977).  A sustained reduction from baseline in fetal oxygenation or 51 
chronic fetal hypoxia is associated with conditions of increased placental vascular resistance, leading 52 
to impaired uteroplacental blood flow.  Chronic fetal hypoxia is therefore associated with 53 
preeclampsia (Kingdom & Kaufmann, 1997), placental insufficiency (Pardi et al. 1993), 54 
chorioamnionitis (Maberry et al. 1990), gestational diabetes (Escobar et al. 2013) and even maternal 55 
obesity (Hayes et al. 2012; Kaplan-Sturk, 2013).  Chronic fetal hypoxia may also occur during 56 
impaired maternal oxygenation, as in maternal smoking (Longo, 1976), maternal respiratory diseases 57 
(Katz & Scheiner, 2008), maternal severe anaemia (Davis et al. 2005) or pregnancy at high altitude 58 
(Makowski et al.1 968; Giussani et al. 2001; Tissot van Patot et al. 2012; Soria et al. 2013).  Acute 59 
episodes of severe fetal hypoxia may result in marked fetal acidosis and cardiovascular compromise 60 
with subsequent hypoxic-ischaemic encephalopathy, which is predictive of developing cerebral palsy 61 
and cognitive disability later in life (Low et al. 1985; Gunn & Bennet, 2009).  Chronic fetal hypoxia 62 
can lead to fetal growth restriction, compromise the development of key organs and systems and 63 
trigger an increased susceptibility to disease in later life (see Giussani & Davidge, 2013 for review).  64 
Therefore, the fetal defence responses to acute and chronic hypoxia are essential to protect against 65 
significant morbidity and mortality in the offspring. Not surprisingly, the elucidation of the fetal 66 
compensatory responses to acute and chronic hypoxia and the mechanisms mediating them remains at 67 
the forefront of perinatal science and obstetric practice today. 68 
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The sheep fetus has long been the experimental model of choice for investigating fetal hypoxia in 69 
vivo.  The fetal defence to acute hypoxia is contingent on the fetal cardiovascular system (Rudolph, 70 
1984; Giussani et al. 1994).  The fetal cardiovascular defence to acute hypoxia and the physiology 71 
underlying it is well established and characterised (see Giussani, 2015 for review).  In response to 72 
acute hypoxia, the fetus elicits bradycardia and redistributes its cardiac output (Cohn et al. 1974).  73 
Parallel measurement of continuous changes in carotid and femoral blood flow show cerebral 74 
vasodilatation and peripheral vasoconstriction, demonstrating in vivo the haemodynamics of the fetal 75 
brain sparing effect (Giussani et al. 1993).  The bradycardia and peripheral vasoconstriction are 76 
triggered exclusively by a carotid chemoreflex (Giussani et al. 1993; Bartelds et al. 1993).  The 77 
peripheral vasoconstriction is then maintained by the release of constrictor hormones into the fetal 78 
circulation (Jones & Robinson, 1975; Fletcher et al. 2006) as well as alterations in local factors, 79 
including the generation of reactive oxygen species (Thakor et al. 2010; 2015; Kane et al. 2012; 80 
2014).  Therefore, the physiology underlying the fetal cardiovascular defence to acute episodes of 81 
hypoxia involves carotid chemoreflex and endocrine components as well as a local oxidant tone acting 82 
at the level of the fetal vasculature (see Giussani, 2015). 83 
 84 
In marked contrast, the fetal in vivo haemodynamic responses to chronic fetal hypoxia and the 85 
mechanisms mediating them are not well characterised or understood.  Progress in this field has been 86 
hampered in part by the inability to record continuous cardiovascular function in the fetus, including 87 
measurement of regional blood flow, as the chronic fetal hypoxia is actually occurring.  Therefore, the 88 
objectives of this work were to introduce to the field a new technique for physiological research and to 89 
show the utility of the technique by investigating the fetal in vivo haemodynamic responses to 90 
significant chronic hypoxia in real time.  We aimed to design and create isobaric hypoxic chambers 91 
able to maintain pregnant sheep for prolonged periods of gestation under controlled long-term 92 
hypoxia, yielding fetal PaO2 levels similar to those measured in human IUGR pregnancy.  Our second 93 
aim was to establish a wireless data acquisition system able to record fetal blood flow signals in 94 
addition to fetal blood pressure and fetal heart rate from free moving ewes as the hypoxic pregnancy 95 
was developing.  Third, to use this system to determine in vivo in real time fetal cardiovascular 96 
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function including parallel measurement of fetal carotid and femoral blood flow and regional oxygen 97 
and glucose delivery during long-term significant hypoxia in late gestation fetal sheep.  We propose 98 
that alterations in the fetal vascular oxidant tone contribute to the fetal redistribution of blood flow 99 
away from the periphery during chronic fetal hypoxia.  Therefore, the fourth aim of this work was to 100 
test the inter-related hypotheses that the fetal circulatory brain sparing response does persist during 101 
significant chronic fetal hypoxia and that an increase in ROS in the fetal circulation is an involved 102 
mechanism.  In vivo generation of ROS in the maternal and the fetal circulation was determined by 103 
measurement of changes in plasma urate and ascorbate concentrations, two of the few accepted 104 
biomarkers of ROS generation within the circulation in vivo (Halliwell & Gutteridge, 2004). 105 
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Methods 106 
Ethical approval 107 
All procedures were performed under the UK Animals (Scientific Procedures) Act 1986 and were 108 
approved by the Ethical Review Committee of the University of Cambridge.  109 
 110 
Surgical preparation, Connection to CamDAS and Post-operative care 111 
Twelve Welsh Mountain pregnant ewes and their singleton fetuses were surgically instrumented using 112 
strict aseptic techniques at 116 ± 1 days of gestational age (term is ca. 145 days), as described in 113 
detail (Fletcher et al. 2000; 2006).  In brief, food but not water was withheld from the pregnant ewe 114 
for 24 h prior to surgery. On the day of surgery, the ewe was transferred to the preoperative room, 115 
where the neck fleece was clipped and anaesthesia was induced by injection of Alfaxan (1.5-2.5 116 
mg.kg-1 alfaxalone; Jurox Ltd, Worcestershire, UK) into the jugular vein. The ewe was then placed on 117 
her back and intubated (Portex© cuffed endotracheal tube; Smiths Medical International Ltd., Kent, 118 
UK) with the aid of a laryngoscope.  Pre-operative anaesthesia was maintained by spontaneous 119 
inhalation of 1.5% isoflurane in O2 (2 L.min-1; IsoFlo©; Abbott laboratories Ltd., Berkshire, UK) and 120 
the abdomen, flanks and medial surfaces of the hind limbs were shaved and cleaned. 121 
 122 
The ewe was then transferred to the surgical suite operating table and the shaved and cleaned surfaces 123 
were scrubbed with alcohol in water, followed by a spray of hibitane solution (Hibitane Plus© in 124 
alcohol and water; 5% chlorohexidine gluconate; Regent Medical Ltd., Manchester, UK) and another 125 
spray of concentrated iodine solution (Povidone-Iodine; Seton Healthcare Group PLC, Oldham, UK).  126 
General anaesthesia (1.5-2.0% isoflurane in 60:40 O2:N2O) was maintained using positive pressure 127 
ventilation in a non-rebreathing circuit (Datex-Ohmeda Ltd, Hatfield, Hertfordshire, UK). Antibiotics 128 
(30 mg.kg-1 I.M. procaine benzylpenicillin; Depocillin; Intervet UK Ltd, Milton Keynes, UK) and an 129 
analgesic agent (1.4 mg.kg-1 S.C. carprofen; Rimadyl; Pfizer Ltd, Kent, UK) were administered 130 
immediately before the start of surgery.  The animal was covered with a plastic sterile drape (Buster 131 
Opcover; Buster, Kruuse, Denmark) and with sterile surgical linen drapes on top, such that only the 132 
midline incision site was left exposed.  Midline abdominal and uterine incisions were then made, the 133 
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fetal hind limbs were exteriorised minimising amniotic fluid loss and, on one side, fetal femoral 134 
arterial (i.d., 0.86 mm; o.d., 1.52 mm; Critchly Electrical Products, NSW, Australia) and venous (i.d., 135 
0.56 mm; o.d., 0.96 mm) catheters were inserted.  The catheter tips were advanced to the descending 136 
aorta and inferior vena cava, respectively.  Another catheter was anchored onto the fetal hind limb for 137 
recording of the reference amniotic pressure. A Transonic flow probe was positioned around the 138 
contra-lateral femoral artery (MC2RS-JSF-WC120-CS12-GCP, Transonic Systems Inc. Ithaca, New 139 
York).  The fetal skin incisions were closed with thin linen suture and the uterine incision was closed 140 
in layers (3-0 Dexon II Bi-colour; Sherwood, Davis & Geck, Gosport, Hants, UK).  The dead space of 141 
the catheters was filled with heparinised saline (80 i.u. heparin ml−1 in 0.9% NaCl) and the catheter 142 
ends were plugged with sterile brass pins. The fetal head was then palpated and exteriorised through a 143 
second uterine incision.  The fetal carotid arteries were isolated and on one side a catheter was 144 
inserted with the tip remaining in the ascending aorta.  A second Transonic flow probe (MC2RS-JSF-145 
WC120-CS12-GCP) was positioned around the contra-lateral carotid artery (Giussani et al. 1993) and 146 
the fetal skin incision and the second uterine incision were closed as before.  All catheters were then 147 
exteriorised via a keyhole incision in the maternal flank on the ewe’s right side whilst the flow probe 148 
leads were exteriorised through a keyhole incision on the ewe’s left flank.  The maternal peritoneum 149 
was then closed in three segments with thick linen suture, and the maternal abdominal skin incision 150 
was sewn together (Ethilon 2-0; Ethicon Ltd., Edinburgh, UK).  A Teflon catheter (i.d.  1.0 mm, o.d. 151 
1.6 mm, Altec, UK) was then inserted into the maternal femoral artery and placed in the descending 152 
aorta, and a maternal venous catheter placed in the inferior vena cava (i.d., 0.86 mm; o.d., 1.52 mm; 153 
Critchly Electrical Products, NSW, Australia).  These catheters were exteriorized through the same 154 
key hole on the ewe’s right side flank. 155 
 156 
A custom made jacket designed to house the bespoke wireless Cambridge Data Acquisition System 157 
(CamDAS, Maastricht Instruments, Maastricht, The Netherlands) was then fitted to the ewe.  The 158 
CamDAS contained a pressure box and a flow box able to record simultaneously 4 pressure and flow 159 
signals, respectively (Figure 1).  It was powered by lithium batteries which were also housed within 160 
the jacket.  The catheters were then connected to pressure transducers (COBE; Argon Division, 161 
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Maxxim Medical, Athens, TX, USA) within the pressure box and the flow probes were connected to 162 
the flow box.   Heart rate was triggered from the blood pressure and flow waveforms.  Recordings of 163 
fetal arterial blood pressure and fetal heart rate, amniotic pressure, fetal carotid blood flow and fetal 164 
femoral blood flow could then be continuously transmitted wirelessly via Bluetooth technology onto a 165 
laptop computer.  At this time the anaesthetic was turned off and the ewe was ventilated until 166 
spontaneous respiratory movements were observed. The ewe was extubated when spontaneous 167 
breathing returned and the animal was allowed to recover in a floor pen with free access to food and 168 
water.   169 
 170 
Ewes wearing jackets with the CamDAS were housed in individual pens in rooms with a 171 
12h:12h/light:dark cycle where they had free access to hay and water and were fed concentrates twice 172 
daily (100 g sheep nuts no. 6; H & C Beart Ltd, Kings Lynn, UK). Antibiotics were administered daily 173 
to the ewe (0.20–0.25 mg kg−1 I.M. depocillin; Mycofarm, Cambridge, UK) for the first three days of 174 
recovery and daily to the fetus I.V. and into the amniotic cavity (600 mg in 2 ml 0.9% NaCl, 175 
benzylpenicillin; Crystapen, Schering-Plough, Animal Health Division, Welwyn Garden City, UK). 176 
Generally, normal feeding patterns were restored within 24-48 h of recovery. Ewes were then 177 
randomly allocated to one of two experimental groups: normoxia (n=6) or chronic hypoxia (n=6).  178 
 179 
Chronic hypoxia protocol 180 
Ewes allocated to chronic hypoxia were housed in one of four bespoke isobaric hypoxic chambers 181 
(Telstar Ace, Dewsbury, West Yorkshire, UK; Figure 1).  These chambers were supplied with variable 182 
amounts of nitrogen and air provided via nitrogen generators and air compressors, respectively, from a 183 
custom designed nitrogen generating system (Domnick Hunter Gas Generation, Gateshead, Tyne & 184 
Wear, UK).  The system operated continuously, automatically switching between adsorption beds of 185 
two nitrogen generators (Domnick Hunter N2MAX112 x 2) to ensure a constant provision of pure 186 
nitrogen gas. The purity of the nitrogen was monitored to ensure only gas of the required purity 187 
reached the application.  Compressed air and compressed nitrogen were then piped to the laboratory 188 
containing the hypoxic chambers and gases were blended to requirements. The inspirate air mixture 189 
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underwent a minimum of 12 changes per hour in each chamber and the incoming air mixture was 190 
passed via silencers able to reduce noise levels within the hypoxic chamber laboratory (76 dB(A)) and 191 
inside each chamber (63 dB(A)) to values lower than those necessary to abide by the Control of Noise 192 
at Work Regulations.  This not only complied with human health and safety and animal welfare 193 
regulations but also provided a tranquil environment for the animal inside each chamber.  All 194 
chambers were equipped with an electronic automatic humidity cool steam injection system (1100-195 
03239 HS-SINF Masalles, Barcelona, Spain) to ensure appropriate humidity in the inspirate 196 
(55±10%).  Ambient PO2, PCO2, humidity and temperature within each chamber were monitored via 197 
sensors, displayed and values recorded continuously via the Trends Building Management System of 198 
the University of Cambridge through a secure Redcare intranet.   In this way, the percentage of 199 
oxygen in the isolators could be controlled with precision continuously over long periods of time.  For 200 
experimental procedures, each chamber had a double transfer port to internalise material and a 201 
manually operated sliding panel to encourage the ewe into a position where daily sampling of blood 202 
could be achieved through glove compartments (Figure 1).  Each chamber incorporated a drinking 203 
bowl on continuous water supply and a rotating food compartment which could be removed for 204 
determining food intake.  The chambers were transparent, allowing ewes to visualise each other.  A 205 
transfer isolation cart could couple two chambers together, allowing ewes to move transiently to an 206 
adjacent chamber maintained at the same oxygen environment.  This was necessary for cleaning the 207 
chambers, which occurred once per week.  Therefore, all experimental and maintenance procedures 208 
could be carried out without interruption of the hypoxic exposure. 209 
 210 
Pregnancies assigned to the chronic hypoxia group were placed inside the chambers under normoxic 211 
conditions (11 L.sec-1 air, equating to 39.6 m3.h-1) for 2 days.  On the 5th post-operative day at 121 ± 1 212 
days of gestation, pregnancies assigned to chronic hypoxia were exposed to ca. 10% PO2 by altering 213 
the incoming gas mixture to 5 L.sec-1 air: 6 L.sec-1 N2. The induction of hypoxia was gradual, 214 
achieving 10% PO2 over 24 h.  Following 11 days of chronic hypoxia exposure, the pregnancies were 215 
returned to breathing normoxic air once again within the chambers.  Cardiovascular data were 216 
transmitted wirelessly via Bluetooth technology and recorded onto a laptop kept outside the hypoxic 217 
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chamber laboratory. This permitted continuous in vivo recordings of the maternal and fetal 218 
cardiovascular data without disturbing the animal’s environment. 219 
 220 
Pregnancies allocated to the normoxia group were housed in a barn in floor pens with the same floor 221 
area as that of the hypoxic chambers.  Both the normoxia and chronic hypoxia groups of ewes were 222 
fed daily the same bespoke maintenance diet made up of concentrate pellets and hay (40g nuts/kg and 223 
3g hay/kg; Manor Farm Feeds Ltd; Oakham, Leicestershire, UK) to facilitate the monitoring of food 224 
intake. 225 
 226 
Blood sampling regimen and analysis 227 
Samples (0.3 ml) of ascending and descending aortic fetal, as well as descending aortic maternal blood 228 
were taken daily for measurement of fetal and maternal blood gas, acid-base and metabolic status.  229 
Arterial blood gas and acid base values were measured using an ABL5 blood gas analyser 230 
(Radiometer; Copenhagen, Denmark; maternal measurements corrected to 38oC, fetal measurements 231 
corrected to 39.5oC). Values for percentage saturation of haemoglobin with oxygen (Sat Hb) and for 232 
the concentration of haemoglobin in blood ([Hb]) were determined using a haemoximeter (OSM3; 233 
Radiometer).  Blood glucose and lactate concentrations were measured using an automated analyser 234 
(Yellow Springs 2300 Stat Plus Glucose/Lactate Analyser; YSI Ltd., Farnborough, UK). Values for 235 
haematocrit were obtained in duplicate using a microhaematocrit centrifuge (Hawksley, UK).  An 236 
additional 1 ml of maternal arterial and fetal arterial blood was taken during baseline (24h prior to 237 
chronic hypoxia) and at +1h, +6h, +1d, +5d and +10d of chronic hypoxia and at +2d post chronic 238 
hypoxia or at equivalent times in normoxic animals for determination of plasma vitamin C and urate 239 
concentrations.   240 
 241 
Determination of plasma urate and vitamin C 242 
Plasma concentrations of urate were measured using an automated Siemens Dimension RxL analyser 243 
(Dimension RxL Max integrated Chemistry system, Siemens, UK, Core Biochemical Assay 244 
Laboratory, Cambridge, UK).  In brief, urate in the plasma (taken from previously unthawed heparin-245 
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treated sample aliquots) is converted to allantoin by the action of uricase (urate oxidase). As urate is 246 
able to absorb light at 293 nm but allantoin is not, the change in absorbance at 293 nm is directly 247 
proportional to the urate concentration in the sample. Additional dilutions of low calibrator solutions 248 
were used to improve the reproducibility of low analyte concentrations. The inter-assay coefficients of 249 
variation were 5.0% at 200 µmol/L and 2.7% at 560 µmol/L.  The lower limit of detection of the assay 250 
was 6 µmol/L. 251 
 252 
Plasma concentrations of ascorbic acid were measured by a fluorimetric technique using a centrifugal 253 
analyser with a fluorescence attachment, according to the method of Vuilleumier and Keck (1989; 254 
Core Biochemical Assay Laboratory, Cambridge, UK).  In brief, aliquots of maternal and fetal plasma 255 
(acidified 1:1 with ice-cold 10 % metaphosphoric acid) were centrifuged and the supernatant stored at 256 
-80oC).  They were then loaded in duplicate onto a black microtitre plate with standards and quality 257 
controls. Addition of ascorbate oxidase converts any vitamin C in the sample to dehydroascorbic acid, 258 
which is then condensed with 1,2-phenyldiamine to form a fluorescent quinoxaline derivative. The 259 
fluorescence is measured on a Fluoroskan Ascent FL (Fluoroskan Ascent FL Microplate Fluorometer 260 
and Luminometer, Thermo Fisher Scientific Inc., UK) and is proportional to the vitamin C 261 
concentration in the sample. The inter-assay coefficients of variation were 7.9% at 27.1 µmol/L and 262 
5.0% at 89.7 µmol/L, the lower limit of detection of the assay was 10 µmol/L. 263 
 264 
Data and statistical analyses 265 
All data are expressed as mean ± SEM.  For the cardiovascular data, minute by minute average values 266 
were downloaded continuously throughout the experiment and imported into an Excel spreadsheet.   267 
Values during 2 h morning (10:00-12:00) and night-time (22:00-24:00) epochs were then averaged for 268 
each day.  Fetal arterial blood oxygen content (O2 content) was calculated using equation (1): 269 
(1) O2 content (mmol.l-1) = 
[ ] 62.0
100
×




 × SatHbHb  270 
Where [Hb] (g.dl-1) is the blood concentration of haemoglobin, SatHb is the percentage oxygen 271 
saturation of haemoglobin and where 1 molecule of Hb (M.W. 64,450) binds 4 molecules of oxygen. 272 
13 
 
The contribution of oxygen dissolved in plasma is regarded as negligible (Owens et al. 1987).  273 
Values for oxygen and for glucose delivery to the fetal ascending and descending aorta were then 274 
calculated using equations (2) and (3), respectively:  275 
(2) Oxygen delivery (µmol.min-1) = O2 content (µmol.ml-1) x appropriate flow (ml.min-1) 276 
(3) Glucose delivery (µmol.min-1) = [Glucose] (µmol.ml-1) x appropriate flow (ml.min-1) 277 
 278 
 For statistical analysis, cardiovascular data were analysed comparing the effect of treatment, time and 279 
interactions between treatment and time using two-way repeated measures ANOVA with the Tukey's 280 
post hoc test. Where relevant, area under the curve or slopes were analysed to better summarise the 281 
data.  Comparison of slopes was performed using the Students t test for unpaired data.  For all 282 
comparisons, statistical significance was accepted when P<0.05. 283 
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Results 284 
 285 
Maternal food consumption, arterial blood gas, acid base and metabolic status 286 
Basal maternal daily food consumption was not different between groups (N: 1.3 ± 0.9 vs. H: 1.1 ± 287 
0.4 kg.d-1).  Exposure to chronic hypoxia did not affect maternal daily food intake (N: 1.5 ± 0.9 vs. H: 288 
1.5 ± 0.9 kg.d-1).  Basal values for maternal arterial blood gas, acid-base and metabolic status were not 289 
different between groups and were within the normal range for Welsh Mountain ewes at the 290 
appropriate time of gestation prior to experimentation (Fletcher et al. 2002; 2006 Fig. 2).  Ewes 291 
exposed to chronic hypoxia had a significant reduction in the partial pressure of arterial oxygen 292 
(mean±SEM: 105.7 ± 3.7 to 42.0 ± 1.2mmHg) and in oxygen saturation (mean±SEM: 103.5 ± 0.5 to 293 
78.6 ± 5.7%) compared to controls (PaO2: 104.2 ± 1.9 and Sat[Hb]: 92.36 ± 1.5) and their own 294 
baseline (P<0.05, Fig. 2). Further, ewes exposed to chronic hypoxia had significantly elevated 295 
haematocrit by the end of exposure relative controls (mean±SEM: 33.9 ± 1.0 vs. 28.5 ± 0.9 %).  These 296 
changes occurred without significant alteration from baseline or between groups in arterial pH, partial 297 
pressure of arterial carbon dioxide, acid-base excess, blood glucose or blood lactate concentrations 298 
(Fig. 2).   Maternal blood lactate concentrations showed a transient 24h increase following the onset 299 
of hypoxia, however these alterations did not reach significance.  While values for partial pressure of 300 
arterial oxygen and oxygen saturation returned towards basal levels, values for haematocrit remained 301 
significantly elevated in the chronic hypoxia ewes following re-oxygenation.   302 
 303 
Fetal arterial blood gas, acid base and metabolic status 304 
Basal values for descending aortic fetal arterial blood gas, acid-base and metabolic status were similar 305 
between groups and were within the normal range for Welsh Mountain singleton sheep fetuses at this 306 
stage of gestation (Fletcher et al. 2002; 2006, Fig. 3). Fetuses exposed to chronic hypoxia had a 307 
significant reduction from baseline in the partial pressure of arterial oxygen (mean±SEM:  20.9 ± 0.5 308 
to 11.5 ± 0.6 mmHg) and oxygen saturation (mean±SEM: 63.0 ± 1.9 to 24.6 ± 2.9 %, P<0.05, Fig. 3).  309 
Fetuses exposed to chronic hypoxia also had significantly elevated haematocrit by the end of exposure 310 
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relative to controls (mean±SEM: 36.1 ± 1.3 vs. 28.0 ± 0.5, P<0.05).  Chronically hypoxic fetuses also 311 
showed a transient increase in arterial pH and reductions in acid base excess by the end of the hypoxic 312 
period, and sustained falls in the partial pressure of arterial carbon dioxide and increases in blood 313 
lactate concentrations during the hypoxic exposure (Fig. 3).  These effects occurred without 314 
significant alteration from baseline in blood glucose concentrations.  While values for all altered 315 
variables returned towards baseline, values for haematocrit remained significantly elevated in the 316 
chronic hypoxia fetuses following re-oxygenation.        317 
 318 
Fetal cardiovascular responses 319 
Basal values (mean±SEM) for fetal descending aortic blood pressure (41.1 ± 0.6 vs. 39.2 ± 0.5 320 
mmHg), fetal heart rate (186.1 ± 2.0 vs. 177.3 ± 1.8 beats.min-1) carotid blood flow (73.3 ± 3.0 vs. 321 
75.7 ± 1.9 ml.min-1) and femoral blood flow (32.3 ± 1.1 vs. 35.5 ± 1.5 ml.min-1) were not different 322 
between normoxic and chronic hypoxic groups and were within the normal range for Welsh Mountain 323 
singleton sheep fetuses at this stage of gestation (Giussani et al. 1993; Jellyman et al. 2005; 2009). 324 
Fetuses undergoing normoxic pregnancy showed progressive increases in arterial blood pressure (41.1 325 
± 0.6 to 50.1 ± 2.3 mmHg), carotid blood flow (73.3 ± 3.0 to 92.3 ± 7.4 ml.min-1) and femoral blood 326 
flow (32.3 ± 1.1 to 35.9 ± 2.5 ml.min-1) and progressive decreases in heart rate (186.1 ± 2.0 to 163.3 ± 327 
7.0 beats.min-1) with advancing gestational age (P<0.05, Fig. 4).  In contrast, in fetuses exposed to 328 
chronic hypoxia, the increment in fetal arterial blood pressure with advancing gestation was 329 
significantly diminished and the decrement in fetal heart rate occurred much later following the onset 330 
of hypoxia but reaching similar levels by the end of the period of exposure (Fig. 4).  Further, fetuses 331 
exposed to chronic hypoxia showed sustained elevations in both carotid and femoral blood flow 332 
during exposure (Table 1 and Fig. 4).  While values for carotid and femoral blood flow returned 333 
towards basal levels, values for arterial blood pressure and for heart rate remained significantly altered 334 
from baseline in the chronic hypoxia fetuses following re-oxygenation.   335 
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Fetal ascending and descending aortic oxygen and glucose delivery  336 
Values for oxygen and glucose delivery to the ascending and descending aortic circulations were 337 
calculated using the values for oxygen content, blood glucose and blood flow in the relevant 338 
circulations shown in Table 1.  Fetuses exposed to chronic hypoxia showed significantly reduced 339 
values for oxygen delivery to both ascending (227.0 ± 9.8 vs. 256.7 ± 7.9 µmol.min-1) and descending 340 
(90.6 ± 4.7 vs. 110.7 ± 4.7 µmol.min-1) aortic circulations relative to normoxic fetuses (Fig. 5).  341 
However, when oxygen delivery was expressed as a ratio between vascular beds, there was a 342 
significant increase in the oxygen delivery to the ascending relative to the descending aortic 343 
circulation during chronic hypoxia (P<0.05, Fig. 5).  In contrast, glucose delivery to either ascending 344 
or descending aorta was unaltered from baseline in fetuses exposed to chronic hypoxia.  However, a 345 
significant increase in glucose delivery to the ascending aorta was calculated when expressed as a 346 
ratio relative to values for the descending aorta by the end of the experimental protocol (Fig. 5).   347 
 348 
Maternal and fetal plasma urate and vitamin C concentrations 349 
Values for basal urate concentrations were significantly higher in the fetal (N: 25.5 ± 1.7 µmol.L-1 and 350 
H: 21.3 ± 2.1 µmol.L-1) than in the maternal (N: 7.5 ± 0.8 µmol.L-1 and H: 6.6 ± 0.7 µmol.L-1) 351 
circulation in both normoxic and hypoxic pregnancy (P<0.05).  While fetal plasma urate 352 
concentrations increased from baseline in fetuses undergoing chronic hypoxia, plasma urate remained 353 
unchanged from baseline in fetuses undergoing normoxic pregnancy and in mothers of normoxic or 354 
hypoxic pregnancy (Figure 6).   In contrast, values for basal vitamin C concentrations were similar in 355 
the fetal (N: 30.4 ± 4.8 µmol.L-1 and H: 31.8 ± 3.5 µmol.L-1) and in the maternal (N: 31.4 ± 4.2 356 
µmol.L-1 and H: 33.9 ± 1.1 µmol.L-1) circulation in both normoxic and hypoxic pregnancy.  However, 357 
while fetal levels of vitamin C remained unchanged from baseline, there was a progressive increase in 358 
maternal plasma vitamin C with advancing gestation in both normoxic and hypoxic pregnancy (Figure 359 
6).  360 
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Discussion 361 
 362 
The data show that exposure of pregnant ewes in late gestation to chronic hypoxia in isobaric 363 
chambers led to sustained reductions in fetal PaO2 to mean levels of ca. 11 mmHg and therefore 364 
similar to those measured in human infants of hypoxic IUGR pregnancy (Hecher et al. 1995) whilst 365 
not affecting maternal food intake. Chronic fetal hypoxia of this magnitude was accompanied by 366 
sustained reductions in fetal PaCO2, progressive increases in fetal haematocrit and variable increases 367 
in fetal blood lactate levels.  Chronically hypoxic fetuses showed an impaired ontogenic increase in 368 
arterial blood pressure and a delayed ontogenic fall in fetal heart rate with advancing gestation.  369 
Parallel recording of carotid and femoral blood flow revealed sustained increases during the period of 370 
chronic hypoxia in chronically hypoxic fetuses, which were greater than those measured in normoxic 371 
fetuses with advancing gestation.  The ratio of oxygen and glucose delivery to the fetal carotid 372 
circulation relative to the femoral circulation increased significantly and progressively in the 373 
chronically hypoxic fetus.  Basal plasma urate concentrations were higher in the fetus than in the 374 
mother and plasma urate increased significantly in the chronically hypoxic fetus.  Conversely, basal 375 
plasma ascorbic acid concentrations were similar in the mother and fetus and plasma ascorbic acid 376 
increased to similar extents only in the maternal circulation in normoxic and hypoxic pregnancy.  377 
These data support the hypotheses tested that the fetal brain sparing response persists during 378 
significant chronic fetal hypoxia and that an increase in ROS in the fetal circulation is an involved 379 
mechanism. 380 
 381 
Several compensatory responses to hypoxia are regulated at least in part by the hypoxia-inducible 382 
factor (HIF) family of transcription factors (Semenza, 2004).  These coordinate intracellular responses 383 
to hypoxia by regulating the expression of hundreds of genes, including erythropoietin or EPO.  The 384 
increased expression of the glycoprotein erythropoietin leads to increased red blood cell production, 385 
which can be measured as an elevation in packed red cell volume or the haematocrit.  The present data 386 
confirm that this level of chronic hypoxia led to significant activation of the HIF-regulated gene 387 
product erythropoietin, as the fetal and to a lesser extent maternal haematocrit increased progressively 388 
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during and immediately following the period of chronic hypoxia.  Additional blood data in the present 389 
manuscript show that chronic hypoxia was accompanied by significant and sustained hypocapnia in 390 
the fetal but not in the maternal circulation.  Fetal hypocapnia could be due to a shift in the fetal 391 
oxidative metabolism, decreasing fetal oxygen consumption and thereby fetal CO2 production and/or 392 
faster clearance of CO2 from the fetal to the maternal circulation.  The sustained elevation in fetal 393 
rather than maternal blood lactate concentration during chronic hypoxia in the present manuscript 394 
indicates an increase in fetal anaerobic metabolism, as has been previously suggested during hypoxic 395 
pregnancy (Lueder et al. 1995; Thompson, 2003).  Bacon et al. (1984) also reported changes in 396 
placental barrier thickness and/or blood flow in chronically hypoxic guinea pig pregnancy. 397 
   398 
Several studies have reported ontogenic increases in fetal arterial blood pressure and fetal peripheral 399 
blood flow and decreases in fetal heart rate with advancing gestation in several species (Reeves et al. 400 
1972; Boddy et al. 1974; Dawes et al. 1980; MacDonald et al. 1983; Kitanaka et al. 1989; Forhead et 401 
al. 2000; Giussani et al. 2005).  The present data are the first to report ontogenic increases in carotid 402 
blood flow with advancing gestation in control fetal sheep.  One previous study reported lower mean 403 
values for fetal arterial blood pressure in chronically hypoxic fetuses of placentally-restricted (PR) 404 
pregnancies (Edwards et al. 1999).  However, others using the same PR model or in hypoxic fetuses 405 
from ovine pregnancies exposed to mild chronic hypoxia have reported similar fetal blood pressure 406 
between control and experimental animals (Kitanaka et al. 1989; Pulgar et al. 2006; 2007; 2009; 407 
Danielson et al. 2005; Poudel et al. 2015).  By comparison, elevated basal values and alterations in 408 
the developmental decline of fetal heart rate with advancing gestation have been more consistently 409 
reported for the chronically hypoxic sheep fetus (Kitanaka et al. 1989; Pulgar et al. 2006).  These 410 
findings are in keeping with a sympathetic dominant influence on cardiovascular control in the 411 
chronically hypoxic fetus (Kitanaka et al. 1989; Edwards et al. 1999). That blood flow to the fetal 412 
cerebral vascular bed increases in a sustained manner in response to chronic hypoxia has been 413 
established for many years (Richardson et al. 1993; Richardson & Bocking, 1998).  In contrast, it has 414 
been generally assumed but widely accepted that blood flow to the peripheral circulations is decreased 415 
in the chronically hypoxic fetus and that this sustained redistribution of blood flow away from the 416 
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periphery contributes to the repeatedly reported asymmetric growth restriction in the chronically 417 
hypoxic fetus (see Barker, 1996; Giussani, 2015).  Two studies support lower basal values for femoral 418 
(Poudel et al. 2015) and carcass (Kamitomo et al. 1993) blood flow in the chronically hypoxic fetus, 419 
with single time point measurements with microspheres or acute recordings of femoral blood flow for 420 
2h.  In this manuscript, we report that continuous longitudinal measurement of fetal femoral blood 421 
flow reveals a sustained increase during chronic hypoxia, akin to the peripheral dilator response to 422 
hypoxia in the adult individual or to the enhanced basal femoral blood flow in adult offspring of 423 
chronically hypoxic pregnancy (Coney & Marshall, 2010).  However, when calculating the actual 424 
delivery of oxygen and glucose to regional circulations, the ratio of substrate delivery to the carotid 425 
relative to the femoral circulation in the fetus shows a progressive increase as the chronic hypoxia 426 
develops.  The latter provides first-hand evidence for persistent brain sparing and continued 427 
redistribution of oxygen delivery away from peripheral circulations and towards the brain in the 428 
chronically hypoxic fetus. 429 
              430 
The use of in vivo models to address questions regarding ROS generation comes with complications, 431 
as free radicals, by their very nature, are difficult to measure in these preparations.   This problem is 432 
further compounded in the present study due to relative inaccessibility of the fetus within the 433 
intrauterine environment within a hypoxic chamber.  Nevertheless, of all techniques available, 434 
dynamic changes in urate and ascorbate concentrations in plasma constitute two of the few accepted 435 
biomarkers of ROS generation within the circulation in vivo (Halliwell & Gutteridge, 2004).  Plasma 436 
urate concentration is an established marker of the activation of the xanthine oxidase (XO) pathway 437 
and, hence, of •O2- generation (Berry & Hare, 2004).   In sheep, ascorbate forms part of the 438 
endogenous antioxidant defence since ovine species possess the enzyme gulonolactone oxidase which 439 
promotes the de novo synthesis of ascorbate via the hexuronic acid pathway of the liver and/or kidney 440 
(Banhegyi et al. 1997).  It is established that plasma ascorbate concentrations also increase throughout 441 
gestation in several species, consistent with a functional role for this antioxidant in prenatal life (Kolb 442 
et al. 1991).  We have previously reported the discovery that enhanced ROS generation contributes to 443 
the fetal peripheral vasoconstrictor response to an episode of acute hypoxia, part of the fetal brain 444 
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sparing effect (Thakor et al. 2010; 2015; Kane et al. 2012; 2014).  ROS do so by quenching NO and 445 
promoting a vascular oxidant tone that complements carotid chemoreflex and endocrine constrictor 446 
mechanisms, aiding the redistribution of blood flow away from peripheral circulations (Giussani, 447 
2015). Data in the present study suggest that there may be tonic activation of the XO pathway during 448 
basal conditions in the fetus relative to the mother, and that the XO pathway in the fetus is more 449 
sensitive to chronic hypoxia than the mother. Since basal arterial PaO2 is about a quarter lower in the 450 
fetal than in the maternal arterial circulation, it is tempting to speculate that the XO pathway is more 451 
active during basal conditions and more responsive to chronic hypoxia in fetal than in adult life, 452 
purely by virtue of this difference in oxygenation (Everest in utero; Barcroft et al. 1993).  The 453 
significant increase in plasma urate concentrations in the circulation of the chronically hypoxic fetus 454 
is consistent with sustained activation of the XO pathway and continued excess ROS generation.  455 
Sustained XO-derived ROS generation may thus contribute to the vascular oxidant tone of the fetal 456 
peripheral circulations, aiding in the shift in the delivery of oxygenated blood away from the fetal 457 
femoral and towards the fetal cerebral circulation in chronically hypoxic pregnancy of this magnitude. 458 
However, it is also possible that differences in circulating urate concentrations between mother and 459 
fetus reflect, in part, different rates of protein degradation and/or differences in renal clearance in the 460 
ewe and offspring. 461 
 462 
Historically, there have been seminal investigations which have induced chronic fetal hypoxia by 463 
impairing uteroplacental blood flow by carunclectomy (Robinson et al. 1979; Poudel et al. 2015), 464 
placental embolization (Boyle et al. 1984; Gagnon et al. 1997; Block et al. 1984), restriction of 465 
uterine blood flow (Richardson & Bocking, 1998; Stein et al. 1999; Lang et al. 2000), single 466 
umbilical artery ligation (Supramaniam et al. 2006; Oyama et al. 1992) and umbilical cord 467 
compression (Itskovitz et al. 1987; Giussani et al. 1997).  However, all of these experimental 468 
manipulations reduce nutrient as well as oxygen delivery to the fetal circulation, preventing 469 
elucidation of the effects of chronic hypoxia on fetal cardiovascular function in isolation.  Other 470 
equally important contributions have included description of fetal or neonatal cardiovascular function 471 
at the conclusion of the chronic hypoxic exposure (Rouwet et al. 2002; Sharma et al. 2006; Tintu et 472 
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al. 2007; Herrera et al. 2008, 2012; Camm et al. 2010;  Lindgren & Altimiras, 2013; Iversen et al. 473 
2014).  A cluster of studies has investigated the effects of chronic hypoxia on fetal cardiovascular 474 
function in vivo, but only reported effects on fetal arterial blood pressure, heart rate and ventricular 475 
output (Alonso et al. 1989; Kitanaka et al. 1989; Kamitomo et al. 1994; Pulgar et al. 2006; 2007; 476 
2009; Tissot van Patot et al. 2012). Another significant series of investigations has exploited the 477 
natural hypobaric hypoxia of high altitude to study the effects on fetal cardiovascular function of 478 
long-term hypoxic gestation (Kamitomo et al. 1992, 1993, 2002; Browne et al. 1997a, 1997b; Onishi 479 
et al. 2003).  While these studies have provided highly important contributions to the field of 480 
knowledge, exposure of pregnant ewes to altitudes between 3000 and 4500 m above sea level yields 481 
late gestation fetal arterial PO2 levels between 15-19 mmHg (Kamitomo et al. 1992, 1993, 2002; 482 
Browne et al. 1997a, 1997b; Onishi et al. 2003; Tissot van Patot et al. 2012).  These values are much 483 
milder than those measured in the umbilical cord of the human hypoxic fetus in IUGR pregnancy, 484 
which are closer to 10-12 mmHg (Hecher et al. 1995).  Investigation of this level of significant 485 
chronic fetal hypoxia using high altitude would involve exposure at 6500-7000 m above sea level 486 
(Gallagher & Hackett, 2004).  Therefore, in summary, the work presented has introduced to the field 487 
of study a new technique for physiological research able to maintain chronically instrumented 488 
maternal and fetal sheep for prolonged periods of gestation under significant and controlled isolated 489 
chronic fetal hypoxia beyond levels that can be achieved by habitable high altitude.  This technology 490 
also permits real time wireless recording in free moving animals of in vivo continuous maternal and 491 
fetal cardiovascular function, including alterations in regional blood flow signals as the hypoxic 492 
pregnancy is developing.  Bioethically, the technology not only improves the physiological quality of 493 
the maternal and fetal in vivo data but it also improves animal welfare.  This is the first time that this 494 
has been possible.  495 
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Legends 520 
 521 
Table 1. Variables used to calculate oxygen and glucose delivery in the chronically hypoxic fetus.  522 
Values are mean±S.E.M variables required to calculate oxygen and glucose delivery throughout the 523 
experimental protocol. Data are shown for fetal ascending and descending arterial oxygen content, 524 
blood glucose and flows in normoxic (N) and hypoxic (H) fetuses (n= 6 both groups).  Significant 525 
differences (P<0.05): *, differences indicating a significant main effect of time compared with 526 
baseline; †, differences indicating a significant main effect of treatment compared with normoxic 527 
pregnancy (two way RM ANOVA + Tukey test). 528 
 529 
Figure 1. Isobaric hypoxic chambers and the CamDAS system.  Each chamber was equipped with 530 
an electronic servo-controlled humidity cool steam injection system to return the appropriate humidity 531 
to the inspirate (i). Ambient PO2, PCO2, humidity and temperature within each chamber were 532 
monitored via sensors (ii). For experimental procedures, each chamber had a double transfer port (iii) 533 
to internalise material and a manually-operated sliding panel (iv) to bring the ewe into a position 534 
where daily sampling of blood could be achieved through glove compartments (v). Each chamber 535 
incorporated a drinking bowl on continuous water supply and a rotating food compartment (vi) for 536 
determining food intake. A sealed transfer isolation cart could be attached to a side exit (vii) to couple 537 
chambers together for cleaning. The CamDAS system was contained in a custom-made sheep jacket 538 
able to hold the pressure acquisition system box (ix) in one side pouch and a box containing the 539 
Transonic flow probe connectors (x) in the other. Cables (xi) connected the two boxes together and 540 
also linked to two battery packs able to power the system for 24 hours. Measurements made using the 541 
data acquisition were transmitted wirelessly via Bluetooth (xiii) to a laptop kept outside the chamber 542 
room (xii) on which it was possible to view continuous recordings of the maternal and fetal 543 
cardiovascular data. 544 
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Figure 2. Maternal blood gas, acid base and metabolic status.  Values are mean±S.E.M. for 545 
pregnant sheep undergoing normoxic (, n=6) or chronic hypoxic (, n=6) pregnancy.  Maternal 546 
blood gas values were corrected to 38oC.  pH, arterial pH; PaCO2, arterial CO2 partial pressure; PaO2, 547 
arterial O2 partial pressure; Sat[Hb], percentage saturation of haemoglobin; ABE, acid/base excess; 548 
Htc, haematocrit; Glucose, blood glucose concentration; Lactate, blood lactate concentration; (N), 549 
normoxic recovery.  Significant differences (P<0.05): *, differences indicating a significant main 550 
effect of time compared with baseline; †, differences indicating a significant main effect of treatment 551 
compared with normoxic pregnancy (two way RM ANOVA + Tukey test).  For Htc, the comparison 552 
of slopes was achieved with the Student’s t test for unpaired data.  553 
 554 
Figure 3. Fetal blood gas, acid base and metabolic status.  Values are mean±S.E.M. for fetal sheep 555 
undergoing normoxic (, n=6) or chronic hypoxic (, n=6) pregnancy.  Fetal blood gas values were 556 
corrected to 39.5oC.  pH, arterial pH; PaCO2, arterial CO2 partial pressure; PaO2, arterial O2 partial 557 
pressure; Sat[Hb], percentage saturation of haemoglobin; ABE, acid/base excess; Htc, haematocrit; 558 
Glucose, blood glucose concentration; Lactate, blood lactate concentration; d, days; hr, hour; (N), 559 
normoxic recovery.  Significant differences (P<0.05): *, differences indicating a significant main 560 
effect of time compared with baseline; †, differences indicating a significant main effect of treatment 561 
compared with normoxic pregnancy (two way RM ANOVA + Tukey test).   562 
 563 
Figure 4. Fetal cardiovascular responses to chronic hypoxia.  Values are mean±S.E.M. for the 564 
change from baseline in cardiovascular variables in fetal sheep undergoing normoxic (, n=6, left) or 565 
chronic hypoxic (, n=6, right) pregnancy. CBF, carotid blood flow; FBF, femoral blood flow; d, 566 
days; hr, hour; BPM, beats per minute; (N), normoxic recovery.  Significant differences (P<0.05): *, 567 
differences indicating a significant main effect of time compared with baseline; †, differences 568 
indicating a significant main effect of treatment compared with normoxic pregnancy (two way RM 569 
ANOVA + Tukey test).  For Descending aortic pressure, the two-way ANOVA represents a 570 
comparison of slopes. For FBF and CBF, the two-way ANOVA represents a comparison of areas 571 
under the curve. 572 
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Figure 5. Fetal carotid and femoral arterial oxygen and glucose delivery in the chronically 573 
hypoxic fetus.  Values are mean±S.E.M. for the change from baseline in oxygen and glucose delivery 574 
in the ascending and the descending aorta and the ratio of these values in fetal sheep undergoing 575 
normoxic (, n=6) or chronic hypoxic (, n=6) pregnancy. d, days; hr, hour; (N), normoxic recovery.  576 
Significant differences (P<0.05): *, differences indicating a significant main effect of time compared 577 
with baseline; †, differences indicating a significant main effect of treatment compared with normoxic 578 
pregnancy (two way RM ANOVA + Tukey test). For the ratio of ascending:descending oxygen 579 
delivery, the two way ANOVA represents an analysis of the area under the curve.   580 
 581 
Figure 6. Fetal and maternal vitamin C and urate levels in the chronically hypoxic fetus.  Values 582 
are mean±S.E.M. for the change from baseline in vitamin C and urate in  pregnant ewes and fetal 583 
sheep undergoing normoxic (, fetus; □, ewe; n=6) or chronic hypoxic (, fetus; ■, ewe; n=6) 584 
pregnancy. d, days; hr, hour; (N), normoxic recovery.  Significant differences (P<0.05): *, differences 585 
indicating a significant main effect of time compared with baseline; †, differences indicating a 586 
significant main effect of treatment compared with normoxic pregnancy (two way RM ANOVA + 587 
Tukey test). For the fetal urate levels the two way ANOVA represents an analysis of the area under 588 
the curve.   589 
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Descending aortic  
O2 content 
mmol.L-1 
Descending aortic  
blood glucose 
mmol.L-1 
Ascending aortic  
O2 content 
mmol.L-1 
Ascending aortic  
blood glucose 
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 N H N H N H N H N H N H 
-3d 2.81±0.08 3.20±0.24 0.89±0.17 0.86±0.03 3.17±0.13 3.90±0.19 0.97±0.26 0.91±0.04 68.8±13.8 69.7±2.4 30.8±4.6 32.0±2.9 
-2d 2.93±0.22 3.17±0.19 0.90±0.11 0.89±0.08 3.23±0.18 3.25±0.05 0.83±0.20 0.85±0.05 71.7±10.4 81.2±4.0 29.6±3.8 36.1±3.4 
-1d 3.14±0.12 3.30±0.07 0.83±0.15 1.20±0.12 3.17±0.14 3.59±0.07 0.98±0.12 1.17±0.12 72.8±9.1 74.3±5.3 28.5±0.6 36.1±3.4 
(-1hr) 2.89±0.44 3.42±0.20 0.72±0.13 0.98±0.11 3.17±0.38 3.65±0.22 0.83±0.07 0.96±0.11 69.7±10.8 81.4±7.1 35.9±0.0 37.3±1.9 
(+6hr) 2.89±0.41 1.82±0.24*† 0.78±0.10 1.02±0.07 3.39±0.47 1.91±0.21*† 0.79±0.09 1.04±0.10 68.2±12.3 104.1±7.5* 35.5±0.4 44.3±4.1 
(+24hr) 2.93±0.50 1.63±0.31*† 0.76±0.16 0.97±0.08 3.34±0.43 1.89±0.32*† 0.73±0.10 0.98±0.10 64.5±8.9 96.8±9.9 33.1±1.2 47.1±3.2* 
d2 2.81±0.19 2.08±0.38* 0.82±0.14 0.92±0.08 3.21±0.15 2.01±0.26*† 0.76±0.11 0.86±0.09 76.9±11.8 90.9±10.7† 35.8±1.1 40.8±3.0*† 
d3 3.05±0.17 2.25±0.37* 0.79±0.09 1.03±0.15 3.54±0.15 2.51±0.27*† 0.82±0.10 0.96±0.14 78.2±8.2 86.2±12.1† 33.8±3.0 36.2±1.1† 
d4 3.03±0.22 2.17±0.30*† 0.77±0.18 0.98±0.03 3.49±0.19 2.56±0.24*† 0.70±0.15 0.89±0.05 74.8±7.7 104.4±11.7* 36.0±3.6 45.6±3.6† 
d5 3.22±0.41 1.89±0.39*† 0.67±0.16 0.84±0.08 3.52±0.20 2.01±0.32*† 0.72±0.12 0.79±0.07 69.3±6.0 96.4±11.6* 35.4±4.3 43.3±1.5 
d6 3.01±0.41 2.16±0.35* 0.61±0.09 0.92±0.04 3.45±0.29 2.44±0.38*† 0.73±0.09 0.96±0.06 77.3±7.1 88.2±11.5* 35.9±5.1 38.8±2.3† 
d7 2.74±0.25 2.64±0.35* 0.72±0.15 0.89±0.08 3.03±0.10 2.81±0.35 0.73±0.16 0.91±0.11 82.2±10.0 103.7±14.6 38.9±4.8 40.8±1.9 
d8 3.20±0.38 1.62±0.17*† 0.82±0.10 0.90±0.11 3.33±0.42 1.79±0.12*† 0.77±0.15 0.92±0.11 81.9±7.8 101.4±7.7* 44.2±1.2 43.2±1.9 
d9 2.86±0.09 2.27±0.40* 0.80±0.11 0.78±0.11 3.29±0.16 2.67±0.20* 0.69±0.13 0.84±0.09 93.0±12.7 82.4±11.6* 45.4±3.3* 35.7±1.7 
d10 2.73±0.11 2.56±0.54* 0.72±0.15 0.81±0.07 3.40±0.04 2.92±0.61* 0.85±0.16 0.84±0.08 90.2±10.1 94.9±8.3 37.0±1.2* 39.5±1.8 
d11 3.11±0.21 2.30±0.16*† 0.62±0.10 0.79±0.04 3.26±0.27 2.69±0.29* 0.80±0.15 0.82±0.07 82.5±5.4 101.3±12.6* 36.2±1.3 39.9±7.2 
d12(N) 3.03±0.20 4.40±0.19† 0.69±0.11 0.62±0.04 3.35±0.17 4.58±0.18† 0.86±0.17 0.65±0.05 83.2±10.3 85.3±7.2* 36.8±1.0 29.7±3.7† 
d13(N) 2.64±0.17 4.35±0.38† 0.69±0.12 0.80±0.06 2.70±0.12 4.82±0.25 0.66±0.13 0.76±0.03 101.8±16.2* 92.9±9.7* 37.1±2.3 30.1±0.7 
 
 
Table 1. Variables used to calculate oxygen and glucose delivery in the chronically hypoxic fetus.  Values are means ± S.E.M variables required to calculate 
oxygen and glucose delivery throughout the experimental protocol. Data are shown for fetal ascending  and descending  arterial oxygen content, blood 
glucose and flows in normoxic (N) and hypoxic (H) fetuses (n= 6 both groups).  Significant differences (P<0.05): *, differences indicating a significant main 
effect of time compared with baseline; †, differences indicating a significant main effect of treatment compared with normoxic pregnancy (two way RM 
ANOVA + Tukey test). 
Figure 1. Isobaric hypoxic chambers and the CamDAS system. Each chamber was equipped with an electronic servo-controlled humidity cool steam injection 
system to return the appropriate humidity to the inspirate (i). Ambient PO2, PCO2, humidity and temperature within each chamber were monitored via 
sensors (ii). For experimental procedures, each chamber had a double transfer port (iii) to internalise material and a manually-operated sliding panel (iv) to 
bring the ewe into a position where daily sampling of blood could be achieved through glove compartments (v). Each chamber incorporated a drinking bowl 
on continuous water supply and a rotating food compartment (vi) for determining food intake. A sealed transfer isolation cart could be attached to a side exit 
(vii) to couple chambers together for cleaning. The camDAS system was contained in a custom-made sheep jacket able to hold the data acquisition system 
box (ix) in one side pouch and a box containing the Transonic flow probe and pressure connectors (x) in the other. Cables (xi) connected the two boxes 
together and also to two battery packs able to power the system for 24 hours. Measurements made using the data acquisition were transmitted wirelessly via 
Bluetooth (xiii) to a laptop kept outside the chamber room (xii) on which it was possible to view continuous recordings of the maternal and fetal 
cardiovascular data. 
Figure 2. Maternal blood gas, acid base and metabolic status.  Values are mean±S.E.M. for pregnant sheep undergoing normoxic (, n=6) or chronic hypoxic 
(, n=6) pregnancy.  Maternal blood gas values were corrected to 38oC.  pH, arterial pH; PaCO2, arterial CO2 partial pressure; PaO2, arterial O2 partial 
pressure; Sat[Hb], percentage saturation of haemoglobin; ABE, acid/base excess; Htc, haematocrit; Glucose, blood glucose concentration; Lactate, blood 
lactate concentration; (N), normoxic recovery.  Significant differences (P<0.05): *, differences indicating a significant main effect of time compared with 
baseline; †, differences indicating a significant main effect of treatment compared with normoxic pregnancy (two way RM ANOVA + Tukey test).  For Htc, the 
comparison of slopes was achieved with the Student’s t test for unpaired data. 
Figure 3. Fetal blood gas, acid base and metabolic status.  Values are mean±S.E.M. for fetal sheep undergoing normoxic (, n=6) or chronic hypoxic (, n=6) 
pregnancy.  Fetal blood gas values were corrected to 39.5oC.  pH, arterial pH; PaCO2, arterial CO2 partial pressure; PaO2, arterial O2 partial pressure; Sat[Hb], 
percentage saturation of haemoglobin; ABE, acid/base excess; Htc, haematocrit; Glucose, blood glucose concentration; Lactate, blood lactate concentration; 
d, days; hr, hour; (N), normoxic recovery.  Significant differences (P<0.05): *, differences indicating a significant main effect of time compared with baseline; 
†, differences indicating a significant main effect of treatment compared with normoxic pregnancy (two way RM ANOVA + Tukey test).   
  
Figure 4. Fetal cardiovascular responses to chronic hypoxia.  Values are mean±S.E.M. for the change from baseline in cardiovascular variables in fetal 
sheep undergoing normoxic (, n=6, left) or chronic hypoxic (, n=6, right) pregnancy. CBF, carotid blood flow; FBF, femoral blood flow; d, days; hr, hour;  
BPM, beats per minute; (N), normoxic recovery.  Significant differences (P<0.05): *, differences indicating a significant main effect of time compared with 
baseline; †, differences indicating a significant main effect of treatment compared with normoxic pregnancy (two way RM ANOVA + Tukey test).  For 
Descending aortic pressure, the two-way ANOVA represents a comparison of slopes. For FBF and CBF, the two-way ANOVA represents a comparison of 
areas under the curve. 
Figure 5. Fetal carotid and femoral arterial oxygen and glucose delivery in the chronically hypoxic fetus.  Values are mean±S.E.M. for the change from 
baseline in oxygen and glucose delivery in the ascending and the descending aorta and the ratio of these values in fetal sheep undergoing normoxic (, n=6) 
or chronic hypoxic (, n=6) pregnancy. d, days; hr, hour; (N), normoxic recovery.  Significant differences (P<0.05): *, differences indicating a significant main 
effect of time compared with baseline; †, differences indicating a significant main effect of treatment compared with normoxic pregnancy (two way RM 
ANOVA + Tukey test). For the ratio of ascending:descending oxygen delivery, the two way ANOVA represents an analysis of the area under the curve.   
Figure 6. Fetal and maternal vitamin C and urate levels in the chronically hypoxic fetus.  Values are mean±S.E.M. for the change from baseline in vitamin C 
and urate in  pregnant ewes and fetal sheep undergoing normoxic (, fetus;     ewe, n=6) or chronic hypoxic (, fetus;     ewe, n=6) pregnancy. d, days; hr, 
hour; (N), normoxic recovery.  Significant differences (P<0.05): *, differences indicating a significant main effect of time compared with baseline; †, 
differences indicating a significant main effect of treatment compared with normoxic pregnancy (two way RM ANOVA + Tukey test). For the fetal urate levels 
the two way ANOVA represents an analysis of the area under the curve.   
